Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1009 9 |
Ultima descărcare din IBN: 2021-12-07 23:24 |
SM ISO690:2012 ŢURCAN, Svetlana, DUMBRAVA, Vlada-Tatiana, BÂRCA, Silvia, TĂNASE, Raisa. Rolul terapiei antibacteriene în colita ulceroasă nespecifică. In: Curierul Medical, 2010, nr. 1(313), pp. 19-25. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 1(313) / 2010 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 19-25 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Role of Antibacterial Treatment in Ulcerative Colitis
The aim of the study was to evaluate the role of short-term treatment with ciprofloxacin and metronidazole in the induction and maintenance of
remission in moderate and severe ulcerative colitis in 156 patients with secondary intestinal infections. Signs of the secondary intestinal infections were
observed at 47 patients (30.1%). Patients with the sings of the secondary intestinal infection were randomized in two groups. Mesalazine, prednisone,
ciprofloxacin and metronidazole were administered to a treatment group of 25 patients and mesalazine with prednisone to a control group of 22.
The introduction of ciprofloxacin and metronidazole in standard treatment schemes is resulted in a decrease of relative risk of relapse by 72%.
|
||||||
Cuvinte-cheie ulcerative colitis, secondary intestinal infections, antibacterial treatment |
||||||
|